164
Followers
1
Posts
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
38.200 -
-1.300
(-3.29%)
Range
37.650 - 39.550
(5.05%)
Open
39.550
Previous Close
39.500
Bid Price
38.000
Bid Volume
('000)
40.5
Ask Price
38.200
Ask Volume
('000)
1
Volume
('000)
774
Value
29,591,225
Remark
-
Delayed prices. Updated at 22 Nov 2024 16:08.
Data powered by
View All Events
164
Loading Chart...
Please login to view stock data and analysis
